Drug Burden Index and Clinical Outcomes
A measure of an individual’s total exposure to anticholinergic and sedative medications, a higher Drug Burden Index (DBI) is associated with an increased risk of
Michael Posey
December 1, 2023
A measure of an individual’s total exposure to anticholinergic and sedative medications, a higher Drug Burden Index (DBI) is associated with an increased risk of
Editorialists describe the history and development of the Beers criteria and other measures of potentially inappropriate prescribing to older adults. “Over the past more than
Compared with the muscle relaxant tizanidine, the use of baclofen in older adults is associated with a significantly increased risk of falls, researchers report. “The
The concurrent use of multiple anticholinergic (ACH) medications (Poly-ACH) can be reduced through physician education, clinical decision support, deprescribing protocols, and designated pharmacist/physician champions, a study
“Deprescribing is the medically supervised process of decreasing or stopping medications that are no longer needed or may be causing harm,” advises a JAMA Patient
In a JAMA Internal Medicine Patient Page article, the process and reasons for medication deprescribing are presented in consumer language. “It is common for people to
Use of an electronic clinical decision support system (eCDSS) to improve prescribing of medications for older adults was safe but not statistically beneficial in a study
Using the example of potassium supplements remaining in a patient’s drug regimen after discontinuation of loop diuretics, authors remind clinicians to be aware of the
In the large, 6-month Care Homes Independent Pharmacist Prescriber Study (CHIPPS), weekly visits to care homes by pharmacist independent prescribers (PIPs) significantly reduced the Drug Burden
In hospitalized patients transitioning to and in postacute care (PAC) facilities, a deprescribing intervention reduced the total medication burden. The effects were sustained at a